Twist Bioscience
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-11.23-13.97-16.34-24.51
Price/Sales ratio
3.863.232.732.36
Earnings per Share (EPS)
$-2.53$-2.03$-1.74$-1.16

Historical Multiples (2016 – 2024)

2016 2017 2018 2019 2020 2021 2022 2023 2024 TTM Median
Valuation Ratios
Price/Earnings ratio
-5.96-4.43-5.22-6.09-21.27-33.93-8.71-5.63-12.55-3.58-13.68
Price/Sales ratio
115.8724.4214.6512.0533.0439.009.324.708.373.5536.02
Price/Book Value ratio
-3.43-1.97-1.844.318.858.882.401.845.541.028.87
Price/Cash Flow ratio
-6.81-5.12-5.63-7.45-20.92-45.98-15.26-8.08-40.89-5.82-14.19
Price/Free Cash Flow ratio
-5.86-4.54-5.33-6.38-19.57-37.05-8.39-6.76-37.89-3.30-12.97
Price/Earnings Growth ratio
N/A-0.120.34-0.132.382.88-0.300.51N/A0.122.63
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
-315.20%-123.08%-26.59%12.79%31.84%39.07%41.37%36.60%42.60%43.59%22.32%
Operating Profit Margin
-1924.01%-543.15%-277.49%-200.14%-130.49%-115.81%-122.33%-88.59%-70.55%-105.47%-165.32%
Pretax Profit Margin
-1943.05%-548.24%-279.20%-197.43%-154.88%-116.39%-112.13%-83.01%-66.51%-99.19%-176.16%
Net Profit Margin
-1943.05%-550.84%-280.15%-197.97%-155.30%-114.93%-107.02%-83.48%-66.69%-99.22%-176.64%
Effective Tax Rate
-1.85%-0.47%-0.34%-0.27%-0.27%1.25%4.56%-0.56%-0.26%-0.03%-0.27%
Return on Assets
-57.65%-69.24%-61.52%-57.57%-35.08%-21.66%-22.66%-26.35%-33.97%-23.53%-46.32%
Return On Equity
57.54%44.47%35.36%-70.79%-41.61%-26.18%-27.59%-32.82%-44.15%-26.60%-56.20%
Return on Capital Employed
-64.40%-76.76%-72.55%-69.49%-32.40%-23.98%-28.59%-30.88%-40.64%-27.55%-50.94%
Liquidity Ratios
Current Ratio
N/AN/AN/A5.279.29N/AN/AN/AN/A6.464.64
Quick Ratio
6.666.964.835.038.958.166.145.344.545.768.55
Cash ratio
3.293.294.351.532.597.384.173.903.183.772.06
Days of Sales Outstanding
116.3079.5277.7881.23106.8578.7472.2465.6140.7075.1692.79
Days of Inventory outstanding
47.5727.7668.3556.4173.04143.97120.2375.3148.92133.7364.72
Operating Cycle
163.88107.29146.14137.64179.89222.71192.47140.9389.63152.27201.30
Days of Payables Outstanding
90.5443.2985.3975.1128.7067.4561.4533.003.3160.3151.91
Cash Conversion Cycle
73.3363.9960.7462.53151.18155.25131.02107.9286.3147.82153.22
Debt Ratios
Debt Ratio
0.140.100.080.040.020.010.01N/A0.020.170.03
Debt Equity Ratio
-0.14-0.06-0.040.050.030.010.01N/A0.030.210.04
Long-term Debt to Capitalization
-0.14-0.07-0.030.020.00N/AN/AN/AN/A0.090.01
Total Debt to Capitalization
-0.17-0.07-0.050.040.030.010.01N/A0.030.110.04
Interest Coverage Ratio
N/AN/AN/A-84.11-149.40N/AN/AN/AN/A-292.54-74.70
Cash Flow to Debt Ratio
-3.45-5.60-6.80-11.37-12.76-11.49-9.11N/A-4.32-1.40-12.06
Company Equity Multiplier
-0.99-0.64-0.571.221.181.201.211.241.291.211.20
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-17.00-4.76-2.60-1.61-1.57-0.84-0.61-0.58-0.20-0.61-1.59
Free Cash Flow / Operating Cash Flow Ratio
1.161.121.051.161.061.241.811.191.071.761.11
Cash Flow Coverage Ratio
-3.45-5.60-6.80-11.37-12.76-11.49-9.11N/A-4.32-1.40-12.06
Short Term Coverage Ratio
-28.23N/A-26.46-26.38-14.60-11.49-9.11N/A-4.32-9.26-20.49
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A